These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 17339185)

  • 1. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls.
    Quiroga T; Goycoolea M; Panes O; Aranda E; Martínez C; Belmont S; Muñoz B; Zúñiga P; Pereira J; Mezzano D
    Haematologica; 2007 Mar; 92(3):357-65. PubMed ID: 17339185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating people with mucocutaneous bleeding suggestive of primary hemostatic defects: a low likelihood of a definitive diagnosis?
    Favaloro EJ
    Haematologica; 2007 Mar; 92(3):292-6. PubMed ID: 17339176
    [No Abstract]   [Full Text] [Related]  

  • 3. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients.
    Quiroga T; Goycoolea M; Muñoz B; Morales M; Aranda E; Panes O; Pereira J; Mezzano D
    J Thromb Haemost; 2004 Jun; 2(6):892-8. PubMed ID: 15140124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Skin and mucous membrane hemorrhages: clinical assessment, study sequence and relative frequency of hereditary diseases of the hemostasis in a Chilean population].
    Quiroga T; Pérez M; Rodríguez S; Muñoz B; Aranda E; Morales M; Verdugo P; Pereira J; Mezzano D
    Rev Med Chil; 1997 Apr; 125(4):409-18. PubMed ID: 9460281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible.
    Pereira J; Quiroga T; Mezzano D
    Semin Thromb Hemost; 2008 Oct; 34(7):654-62. PubMed ID: 19085766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders.
    Gupta PK; Charan VD; Saxena R
    Ann Hematol; 2007 Jun; 86(6):403-7. PubMed ID: 17375300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time.
    Podda GM; Bucciarelli P; Lussana F; Lecchi A; Cattaneo M
    J Thromb Haemost; 2007 Dec; 5(12):2393-8. PubMed ID: 18034764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttal.
    Favaloro EJ
    J Thromb Haemost; 2004 Dec; 2(12):2280-2; author reply 2283-5. PubMed ID: 15613055
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombin generation in platelet-poor plasma is normal in patients with hereditary mucocutaneous haemorrhages.
    Quiroga T; Goycoolea M; Giesen PL; Morales M; Muñoz B; Aranda E; Rodríguez S; Panes O; Martínez C; Pereira J; Mezzano D
    Pathophysiol Haemost Thromb; 2003; 33(1):30-5. PubMed ID: 12853710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders.
    Sidonio RF; Bryant PC; Di Paola J; Hale S; Heiman M; Horowitz GS; Humphrey C; Jaffray J; Joyner LC; Kasthuri R; Konkle BA; Kouides PA; Montgomery R; Neeves K; Randi AM; Scappe N; Tarango C; Tickle K; Trapane P; Wang M; Waters B; Flood VH
    Expert Rev Hematol; 2023 Mar; 16(sup1):39-54. PubMed ID: 36920856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The power of a standardized bleeding score in diagnosing paediatric type 1 von Willebrand's disease and platelet function defects.
    Marcus PD; Nire KG; Grooms L; Klima J; O'Brien SH
    Haemophilia; 2011 Mar; 17(2):223-7. PubMed ID: 20860605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
    Favaloro EJ
    Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ISTH bleeding assessment tool and platelet function analyzer in children with mild inherited platelet function disorders.
    Alhaj D; Hagedorn N; Cuntz F; Reschke M; Schuldes J; Ruthenberg J; Bakchoul T; Greinacher A; Holzhauer S
    Eur J Haematol; 2024 Jul; 113(1):54-65. PubMed ID: 38549165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A diagnostic approach to relatively common mild bleeding symptoms: screening of congenital mild bleeding disorders].
    Kaneko M
    Rinsho Ketsueki; 2018; 59(10):2247-2254. PubMed ID: 30305532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
    Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
    Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
    Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
    Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.